Inflammatory response time course, HUVEC (Wada et al., 2009)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
LEF1
|
ENSG00000138795.5 | lymphoid enhancer binding factor 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
LEF1 | hg19_v2_chr4_-_109089573_109089585, hg19_v2_chr4_-_109090106_109090124 | -0.38 | 5.8e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr13_-_72441315 | 10.39 |
ENST00000305425.4
ENST00000313174.7 ENST00000354591.4 |
DACH1
|
dachshund homolog 1 (Drosophila) |
chr13_-_72440901 | 9.97 |
ENST00000359684.2
|
DACH1
|
dachshund homolog 1 (Drosophila) |
chr4_-_186877502 | 5.82 |
ENST00000431902.1
ENST00000284776.7 ENST00000415274.1 |
SORBS2
|
sorbin and SH3 domain containing 2 |
chr1_+_100111580 | 5.48 |
ENST00000605497.1
|
PALMD
|
palmdelphin |
chr1_+_100111479 | 5.27 |
ENST00000263174.4
|
PALMD
|
palmdelphin |
chr13_+_32605437 | 4.27 |
ENST00000380250.3
|
FRY
|
furry homolog (Drosophila) |
chr15_+_96869165 | 3.85 |
ENST00000421109.2
|
NR2F2
|
nuclear receptor subfamily 2, group F, member 2 |
chr1_+_82266053 | 3.82 |
ENST00000370715.1
ENST00000370713.1 ENST00000319517.6 ENST00000370717.2 ENST00000394879.1 ENST00000271029.4 ENST00000335786.5 |
LPHN2
|
latrophilin 2 |
chr3_-_18466026 | 3.56 |
ENST00000417717.2
|
SATB1
|
SATB homeobox 1 |
chr7_-_27219849 | 3.50 |
ENST00000396344.4
|
HOXA10
|
homeobox A10 |
chr3_-_66024213 | 3.26 |
ENST00000483466.1
|
MAGI1
|
membrane associated guanylate kinase, WW and PDZ domain containing 1 |
chr1_+_78383813 | 3.14 |
ENST00000342754.5
|
NEXN
|
nexilin (F actin binding protein) |
chr1_+_61330931 | 2.88 |
ENST00000371191.1
|
NFIA
|
nuclear factor I/A |
chr8_-_80993010 | 2.76 |
ENST00000537855.1
ENST00000520527.1 ENST00000517427.1 ENST00000448733.2 ENST00000379097.3 |
TPD52
|
tumor protein D52 |
chr1_+_61548225 | 2.71 |
ENST00000371187.3
|
NFIA
|
nuclear factor I/A |
chr7_-_27213893 | 2.70 |
ENST00000283921.4
|
HOXA10
|
homeobox A10 |
chr4_-_16900184 | 2.69 |
ENST00000515064.1
|
LDB2
|
LIM domain binding 2 |
chr4_-_16900410 | 2.69 |
ENST00000304523.5
|
LDB2
|
LIM domain binding 2 |
chr4_-_16900217 | 2.65 |
ENST00000441778.2
|
LDB2
|
LIM domain binding 2 |
chr4_-_16900242 | 2.64 |
ENST00000502640.1
ENST00000506732.1 |
LDB2
|
LIM domain binding 2 |
chr15_-_52944231 | 2.60 |
ENST00000546305.2
|
FAM214A
|
family with sequence similarity 214, member A |
chr9_+_36036430 | 2.54 |
ENST00000377966.3
|
RECK
|
reversion-inducing-cysteine-rich protein with kazal motifs |
chr3_-_148804275 | 2.47 |
ENST00000392912.2
ENST00000465259.1 ENST00000310053.5 ENST00000494055.1 |
HLTF
|
helicase-like transcription factor |
chr18_+_72922710 | 2.41 |
ENST00000322038.5
|
TSHZ1
|
teashirt zinc finger homeobox 1 |
chr8_-_124553437 | 2.35 |
ENST00000517956.1
ENST00000443022.2 |
FBXO32
|
F-box protein 32 |
chr3_+_20081515 | 2.30 |
ENST00000263754.4
|
KAT2B
|
K(lysine) acetyltransferase 2B |
chr1_+_61548374 | 2.27 |
ENST00000485903.2
ENST00000371185.2 ENST00000371184.2 |
NFIA
|
nuclear factor I/A |
chr8_-_93107443 | 2.08 |
ENST00000360348.2
ENST00000520428.1 ENST00000518992.1 ENST00000520556.1 ENST00000518317.1 ENST00000521319.1 ENST00000521375.1 ENST00000518449.1 |
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related) |
chr1_+_84630053 | 2.05 |
ENST00000394838.2
ENST00000370682.3 ENST00000432111.1 |
PRKACB
|
protein kinase, cAMP-dependent, catalytic, beta |
chr2_+_176994408 | 2.02 |
ENST00000429017.1
ENST00000313173.4 ENST00000544999.1 |
HOXD8
|
homeobox D8 |
chr2_-_183387430 | 1.96 |
ENST00000410103.1
|
PDE1A
|
phosphodiesterase 1A, calmodulin-dependent |
chr3_+_107244229 | 1.87 |
ENST00000456419.1
ENST00000402163.2 |
BBX
|
bobby sox homolog (Drosophila) |
chr1_+_164528866 | 1.85 |
ENST00000420696.2
|
PBX1
|
pre-B-cell leukemia homeobox 1 |
chr4_+_30721968 | 1.83 |
ENST00000361762.2
|
PCDH7
|
protocadherin 7 |
chr1_+_6845578 | 1.80 |
ENST00000467404.2
ENST00000439411.2 |
CAMTA1
|
calmodulin binding transcription activator 1 |
chr9_+_133971863 | 1.74 |
ENST00000372309.3
|
AIF1L
|
allograft inflammatory factor 1-like |
chr9_+_133971909 | 1.69 |
ENST00000247291.3
ENST00000372302.1 ENST00000372300.1 ENST00000372298.1 |
AIF1L
|
allograft inflammatory factor 1-like |
chr3_-_141747439 | 1.69 |
ENST00000467667.1
|
TFDP2
|
transcription factor Dp-2 (E2F dimerization partner 2) |
chr20_+_30598231 | 1.63 |
ENST00000300415.8
ENST00000262659.8 |
CCM2L
|
cerebral cavernous malformation 2-like |
chr1_+_6845497 | 1.61 |
ENST00000473578.1
ENST00000557126.1 |
CAMTA1
|
calmodulin binding transcription activator 1 |
chr3_-_169381183 | 1.61 |
ENST00000494292.1
|
MECOM
|
MDS1 and EVI1 complex locus |
chr8_-_17579726 | 1.61 |
ENST00000381861.3
|
MTUS1
|
microtubule associated tumor suppressor 1 |
chr5_-_88179302 | 1.61 |
ENST00000504921.2
|
MEF2C
|
myocyte enhancer factor 2C |
chr7_+_116312411 | 1.55 |
ENST00000456159.1
ENST00000397752.3 ENST00000318493.6 |
MET
|
met proto-oncogene |
chr2_-_165424973 | 1.54 |
ENST00000543549.1
|
GRB14
|
growth factor receptor-bound protein 14 |
chr1_-_211752073 | 1.53 |
ENST00000367001.4
|
SLC30A1
|
solute carrier family 30 (zinc transporter), member 1 |
chr3_+_152017924 | 1.52 |
ENST00000465907.2
ENST00000492948.1 ENST00000485509.1 ENST00000464596.1 |
MBNL1
|
muscleblind-like splicing regulator 1 |
chr3_-_149375783 | 1.50 |
ENST00000467467.1
ENST00000460517.1 ENST00000360632.3 |
WWTR1
|
WW domain containing transcription regulator 1 |
chr10_+_54074033 | 1.47 |
ENST00000373970.3
|
DKK1
|
dickkopf WNT signaling pathway inhibitor 1 |
chr11_-_94965667 | 1.42 |
ENST00000542176.1
ENST00000278499.2 |
SESN3
|
sestrin 3 |
chr13_+_39612485 | 1.39 |
ENST00000379599.2
|
NHLRC3
|
NHL repeat containing 3 |
chr2_-_157189180 | 1.38 |
ENST00000539077.1
ENST00000424077.1 ENST00000426264.1 ENST00000339562.4 ENST00000421709.1 |
NR4A2
|
nuclear receptor subfamily 4, group A, member 2 |
chr13_-_67802549 | 1.37 |
ENST00000328454.5
ENST00000377865.2 |
PCDH9
|
protocadherin 9 |
chr6_+_143929307 | 1.34 |
ENST00000427704.2
ENST00000305766.6 |
PHACTR2
|
phosphatase and actin regulator 2 |
chr8_+_29952914 | 1.33 |
ENST00000321250.8
ENST00000518001.1 ENST00000520682.1 ENST00000442880.2 ENST00000523116.1 |
LEPROTL1
|
leptin receptor overlapping transcript-like 1 |
chr13_+_39612442 | 1.32 |
ENST00000470258.1
ENST00000379600.3 |
NHLRC3
|
NHL repeat containing 3 |
chrX_+_80457442 | 1.31 |
ENST00000373212.5
|
SH3BGRL
|
SH3 domain binding glutamic acid-rich protein like |
chr12_+_79258547 | 1.30 |
ENST00000457153.2
|
SYT1
|
synaptotagmin I |
chr2_-_183387064 | 1.30 |
ENST00000536095.1
ENST00000331935.6 ENST00000358139.2 ENST00000456212.1 |
PDE1A
|
phosphodiesterase 1A, calmodulin-dependent |
chr8_-_93107696 | 1.30 |
ENST00000436581.2
ENST00000520583.1 ENST00000519061.1 |
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related) |
chr3_-_141747459 | 1.29 |
ENST00000477292.1
ENST00000478006.1 ENST00000495310.1 ENST00000486111.1 |
TFDP2
|
transcription factor Dp-2 (E2F dimerization partner 2) |
chr18_-_52989217 | 1.28 |
ENST00000570287.2
|
TCF4
|
transcription factor 4 |
chrX_+_86772787 | 1.24 |
ENST00000373114.4
|
KLHL4
|
kelch-like family member 4 |
chr5_-_90679145 | 1.19 |
ENST00000265138.3
|
ARRDC3
|
arrestin domain containing 3 |
chr10_-_116444371 | 1.18 |
ENST00000533213.2
ENST00000369252.4 |
ABLIM1
|
actin binding LIM protein 1 |
chr20_+_11898507 | 1.15 |
ENST00000378226.2
|
BTBD3
|
BTB (POZ) domain containing 3 |
chrX_-_80457385 | 1.14 |
ENST00000451455.1
ENST00000436386.1 ENST00000358130.2 |
HMGN5
|
high mobility group nucleosome binding domain 5 |
chr18_-_53089723 | 1.14 |
ENST00000561992.1
ENST00000562512.2 |
TCF4
|
transcription factor 4 |
chr15_+_57511609 | 1.13 |
ENST00000543579.1
ENST00000537840.1 ENST00000343827.3 |
TCF12
|
transcription factor 12 |
chr2_+_181845843 | 1.13 |
ENST00000602710.1
|
UBE2E3
|
ubiquitin-conjugating enzyme E2E 3 |
chr8_-_93107827 | 1.12 |
ENST00000520724.1
ENST00000518844.1 |
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related) |
chr5_-_88178964 | 1.10 |
ENST00000513252.1
ENST00000508569.1 ENST00000510942.1 ENST00000506554.1 |
MEF2C
|
myocyte enhancer factor 2C |
chrX_-_119694538 | 1.10 |
ENST00000371322.5
|
CUL4B
|
cullin 4B |
chr1_+_84630367 | 1.08 |
ENST00000370680.1
|
PRKACB
|
protein kinase, cAMP-dependent, catalytic, beta |
chr7_+_16793160 | 1.08 |
ENST00000262067.4
|
TSPAN13
|
tetraspanin 13 |
chr13_-_45150392 | 1.07 |
ENST00000501704.2
|
TSC22D1
|
TSC22 domain family, member 1 |
chr21_+_17791648 | 1.06 |
ENST00000602892.1
ENST00000418813.2 ENST00000435697.1 |
LINC00478
|
long intergenic non-protein coding RNA 478 |
chr5_+_95066823 | 1.06 |
ENST00000506817.1
ENST00000379982.3 |
RHOBTB3
|
Rho-related BTB domain containing 3 |
chr8_+_29953163 | 1.06 |
ENST00000518192.1
|
LEPROTL1
|
leptin receptor overlapping transcript-like 1 |
chrX_-_32173579 | 1.06 |
ENST00000359836.1
ENST00000343523.2 ENST00000378707.3 ENST00000541735.1 ENST00000474231.1 |
DMD
|
dystrophin |
chr11_-_66445219 | 1.06 |
ENST00000525754.1
ENST00000531969.1 ENST00000524637.1 ENST00000531036.2 ENST00000310046.4 |
RBM4B
|
RNA binding motif protein 4B |
chr5_-_88179017 | 1.05 |
ENST00000514028.1
ENST00000514015.1 ENST00000503075.1 ENST00000437473.2 |
MEF2C
|
myocyte enhancer factor 2C |
chr11_-_119234876 | 1.05 |
ENST00000525735.1
|
USP2
|
ubiquitin specific peptidase 2 |
chr3_-_141747950 | 1.02 |
ENST00000497579.1
|
TFDP2
|
transcription factor Dp-2 (E2F dimerization partner 2) |
chr15_+_96873921 | 1.01 |
ENST00000394166.3
|
NR2F2
|
nuclear receptor subfamily 2, group F, member 2 |
chr7_-_27224842 | 1.00 |
ENST00000517402.1
|
HOXA11
|
homeobox A11 |
chr17_-_46690839 | 0.98 |
ENST00000498634.2
|
HOXB8
|
homeobox B8 |
chr7_-_27224795 | 0.97 |
ENST00000006015.3
|
HOXA11
|
homeobox A11 |
chr1_+_93913713 | 0.97 |
ENST00000604705.1
ENST00000370253.2 |
FNBP1L
|
formin binding protein 1-like |
chr1_+_185703513 | 0.96 |
ENST00000271588.4
ENST00000367492.2 |
HMCN1
|
hemicentin 1 |
chr12_-_6772303 | 0.95 |
ENST00000396807.4
ENST00000446105.2 ENST00000341550.4 |
ING4
|
inhibitor of growth family, member 4 |
chr11_-_47207390 | 0.95 |
ENST00000539589.1
ENST00000528462.1 |
PACSIN3
|
protein kinase C and casein kinase substrate in neurons 3 |
chr14_-_21270995 | 0.94 |
ENST00000555698.1
ENST00000397970.4 ENST00000340900.3 |
RNASE1
|
ribonuclease, RNase A family, 1 (pancreatic) |
chr16_-_15736881 | 0.94 |
ENST00000540441.2
|
KIAA0430
|
KIAA0430 |
chr11_+_92085262 | 0.93 |
ENST00000298047.6
ENST00000409404.2 ENST00000541502.1 |
FAT3
|
FAT atypical cadherin 3 |
chr21_+_17791838 | 0.92 |
ENST00000453910.1
|
LINC00478
|
long intergenic non-protein coding RNA 478 |
chr1_+_87797351 | 0.91 |
ENST00000370542.1
|
LMO4
|
LIM domain only 4 |
chr3_-_65583561 | 0.90 |
ENST00000460329.2
|
MAGI1
|
membrane associated guanylate kinase, WW and PDZ domain containing 1 |
chr19_+_1249869 | 0.90 |
ENST00000591446.2
|
MIDN
|
midnolin |
chr6_-_159466042 | 0.90 |
ENST00000338313.5
|
TAGAP
|
T-cell activation RhoGTPase activating protein |
chr2_+_198669365 | 0.88 |
ENST00000428675.1
|
PLCL1
|
phospholipase C-like 1 |
chr3_+_141105235 | 0.88 |
ENST00000503809.1
|
ZBTB38
|
zinc finger and BTB domain containing 38 |
chr11_-_130184555 | 0.87 |
ENST00000525842.1
|
ZBTB44
|
zinc finger and BTB domain containing 44 |
chrX_-_10588595 | 0.86 |
ENST00000423614.1
ENST00000317552.4 |
MID1
|
midline 1 (Opitz/BBB syndrome) |
chr2_+_179184955 | 0.86 |
ENST00000315022.2
|
OSBPL6
|
oxysterol binding protein-like 6 |
chr20_-_23066953 | 0.86 |
ENST00000246006.4
|
CD93
|
CD93 molecule |
chr3_-_112320749 | 0.85 |
ENST00000610103.1
|
RP11-572C15.6
|
RP11-572C15.6 |
chr4_+_170581213 | 0.85 |
ENST00000507875.1
|
CLCN3
|
chloride channel, voltage-sensitive 3 |
chrX_+_86772707 | 0.84 |
ENST00000373119.4
|
KLHL4
|
kelch-like family member 4 |
chrX_-_10588459 | 0.84 |
ENST00000380782.2
|
MID1
|
midline 1 (Opitz/BBB syndrome) |
chr15_-_65067773 | 0.83 |
ENST00000300069.4
|
RBPMS2
|
RNA binding protein with multiple splicing 2 |
chr6_-_112575838 | 0.83 |
ENST00000455073.1
|
LAMA4
|
laminin, alpha 4 |
chr12_+_9067123 | 0.83 |
ENST00000543824.1
|
PHC1
|
polyhomeotic homolog 1 (Drosophila) |
chr17_-_63557759 | 0.83 |
ENST00000307078.5
|
AXIN2
|
axin 2 |
chr7_+_115850547 | 0.82 |
ENST00000358204.4
ENST00000455989.1 ENST00000537767.1 |
TES
|
testis derived transcript (3 LIM domains) |
chr11_+_5410607 | 0.81 |
ENST00000328611.3
|
OR51M1
|
olfactory receptor, family 51, subfamily M, member 1 |
chr9_+_82186682 | 0.78 |
ENST00000376552.2
|
TLE4
|
transducin-like enhancer of split 4 (E(sp1) homolog, Drosophila) |
chr1_+_16085244 | 0.75 |
ENST00000400773.1
|
FBLIM1
|
filamin binding LIM protein 1 |
chr3_+_183353356 | 0.75 |
ENST00000242810.6
ENST00000493074.1 ENST00000437402.1 ENST00000454495.2 ENST00000473045.1 ENST00000468101.1 ENST00000427201.2 ENST00000482138.1 ENST00000454652.2 |
KLHL24
|
kelch-like family member 24 |
chr7_+_80275621 | 0.74 |
ENST00000426978.1
ENST00000432207.1 |
CD36
|
CD36 molecule (thrombospondin receptor) |
chr15_-_101792137 | 0.72 |
ENST00000254190.3
|
CHSY1
|
chondroitin sulfate synthase 1 |
chr17_-_46623441 | 0.72 |
ENST00000330070.4
|
HOXB2
|
homeobox B2 |
chr1_+_66999268 | 0.71 |
ENST00000371039.1
ENST00000424320.1 |
SGIP1
|
SH3-domain GRB2-like (endophilin) interacting protein 1 |
chr1_+_66797687 | 0.71 |
ENST00000371045.5
ENST00000531025.1 ENST00000526197.1 |
PDE4B
|
phosphodiesterase 4B, cAMP-specific |
chr6_-_112575912 | 0.71 |
ENST00000522006.1
ENST00000230538.7 ENST00000519932.1 |
LAMA4
|
laminin, alpha 4 |
chr4_+_113152978 | 0.71 |
ENST00000309703.6
|
AP1AR
|
adaptor-related protein complex 1 associated regulatory protein |
chrX_-_50557014 | 0.70 |
ENST00000376020.2
|
SHROOM4
|
shroom family member 4 |
chr12_-_6233828 | 0.70 |
ENST00000572068.1
ENST00000261405.5 |
VWF
|
von Willebrand factor |
chr2_+_66666432 | 0.69 |
ENST00000495021.2
|
MEIS1
|
Meis homeobox 1 |
chr10_+_18948311 | 0.69 |
ENST00000377275.3
|
ARL5B
|
ADP-ribosylation factor-like 5B |
chrX_+_135229600 | 0.69 |
ENST00000370690.3
|
FHL1
|
four and a half LIM domains 1 |
chr14_-_23624511 | 0.68 |
ENST00000529705.2
|
SLC7A8
|
solute carrier family 7 (amino acid transporter light chain, L system), member 8 |
chr18_-_53069419 | 0.68 |
ENST00000570177.2
|
TCF4
|
transcription factor 4 |
chr9_+_82186872 | 0.68 |
ENST00000376544.3
ENST00000376520.4 |
TLE4
|
transducin-like enhancer of split 4 (E(sp1) homolog, Drosophila) |
chr11_+_92085707 | 0.67 |
ENST00000525166.1
|
FAT3
|
FAT atypical cadherin 3 |
chr7_+_107224364 | 0.67 |
ENST00000491150.1
|
BCAP29
|
B-cell receptor-associated protein 29 |
chr21_+_17443434 | 0.66 |
ENST00000400178.2
|
LINC00478
|
long intergenic non-protein coding RNA 478 |
chr5_+_161274940 | 0.66 |
ENST00000393943.4
|
GABRA1
|
gamma-aminobutyric acid (GABA) A receptor, alpha 1 |
chr2_-_211341411 | 0.66 |
ENST00000233714.4
ENST00000443314.1 ENST00000441020.3 ENST00000450366.2 ENST00000431941.2 |
LANCL1
|
LanC lantibiotic synthetase component C-like 1 (bacterial) |
chr16_-_30122717 | 0.66 |
ENST00000566613.1
|
GDPD3
|
glycerophosphodiester phosphodiesterase domain containing 3 |
chr17_-_27503770 | 0.65 |
ENST00000533112.1
|
MYO18A
|
myosin XVIIIA |
chr11_-_130184470 | 0.64 |
ENST00000357899.4
ENST00000397753.1 |
ZBTB44
|
zinc finger and BTB domain containing 44 |
chr14_+_75230011 | 0.64 |
ENST00000552421.1
ENST00000325680.7 ENST00000238571.3 |
YLPM1
|
YLP motif containing 1 |
chr8_-_16859690 | 0.64 |
ENST00000180166.5
|
FGF20
|
fibroblast growth factor 20 |
chr5_+_175288631 | 0.64 |
ENST00000509837.1
|
CPLX2
|
complexin 2 |
chr7_+_7811992 | 0.64 |
ENST00000406829.1
|
RPA3-AS1
|
RPA3 antisense RNA 1 |
chr14_+_21236586 | 0.63 |
ENST00000326783.3
|
EDDM3B
|
epididymal protein 3B |
chr5_-_138210977 | 0.63 |
ENST00000274711.6
ENST00000521094.2 |
LRRTM2
|
leucine rich repeat transmembrane neuronal 2 |
chr19_-_3029011 | 0.63 |
ENST00000590536.1
ENST00000587137.1 ENST00000455444.2 ENST00000262953.6 |
TLE2
|
transducin-like enhancer of split 2 (E(sp1) homolog, Drosophila) |
chrX_+_135229559 | 0.63 |
ENST00000394155.2
|
FHL1
|
four and a half LIM domains 1 |
chr21_+_17443521 | 0.63 |
ENST00000456342.1
|
LINC00478
|
long intergenic non-protein coding RNA 478 |
chr9_-_97356075 | 0.62 |
ENST00000375337.3
|
FBP2
|
fructose-1,6-bisphosphatase 2 |
chr20_+_10199468 | 0.62 |
ENST00000254976.2
ENST00000304886.2 |
SNAP25
|
synaptosomal-associated protein, 25kDa |
chr15_-_82338460 | 0.62 |
ENST00000558133.1
ENST00000329713.4 |
MEX3B
|
mex-3 RNA binding family member B |
chr11_-_104769141 | 0.62 |
ENST00000508062.1
ENST00000422698.2 |
CASP12
|
caspase 12 (gene/pseudogene) |
chr9_+_33629119 | 0.62 |
ENST00000331828.4
|
TRBV21OR9-2
|
T cell receptor beta variable 21/OR9-2 (pseudogene) |
chrX_-_10645773 | 0.61 |
ENST00000453318.2
|
MID1
|
midline 1 (Opitz/BBB syndrome) |
chr1_-_234667504 | 0.61 |
ENST00000421207.1
ENST00000435574.1 |
RP5-855F14.1
|
RP5-855F14.1 |
chr14_+_89290965 | 0.61 |
ENST00000345383.5
ENST00000536576.1 ENST00000346301.4 ENST00000338104.6 ENST00000354441.6 ENST00000380656.2 ENST00000556651.1 ENST00000554686.1 |
TTC8
|
tetratricopeptide repeat domain 8 |
chr7_-_19813192 | 0.60 |
ENST00000422233.1
ENST00000433641.1 |
TMEM196
|
transmembrane protein 196 |
chr16_+_53242350 | 0.60 |
ENST00000565442.1
|
CHD9
|
chromodomain helicase DNA binding protein 9 |
chr4_+_113152881 | 0.59 |
ENST00000274000.5
|
AP1AR
|
adaptor-related protein complex 1 associated regulatory protein |
chr2_-_183387283 | 0.59 |
ENST00000435564.1
|
PDE1A
|
phosphodiesterase 1A, calmodulin-dependent |
chr14_-_35182994 | 0.59 |
ENST00000341223.3
|
CFL2
|
cofilin 2 (muscle) |
chr22_-_32860427 | 0.59 |
ENST00000534972.1
ENST00000397450.1 ENST00000397452.1 |
BPIFC
|
BPI fold containing family C |
chrX_-_63425561 | 0.58 |
ENST00000374869.3
ENST00000330258.3 |
AMER1
|
APC membrane recruitment protein 1 |
chr1_-_94079648 | 0.58 |
ENST00000370247.3
|
BCAR3
|
breast cancer anti-estrogen resistance 3 |
chr13_+_76210448 | 0.58 |
ENST00000377499.5
|
LMO7
|
LIM domain 7 |
chr8_+_39770803 | 0.58 |
ENST00000518237.1
|
IDO1
|
indoleamine 2,3-dioxygenase 1 |
chrX_-_19817869 | 0.58 |
ENST00000379698.4
|
SH3KBP1
|
SH3-domain kinase binding protein 1 |
chrX_+_54835493 | 0.57 |
ENST00000396224.1
|
MAGED2
|
melanoma antigen family D, 2 |
chr9_+_504674 | 0.57 |
ENST00000382297.2
|
KANK1
|
KN motif and ankyrin repeat domains 1 |
chr7_-_148581360 | 0.56 |
ENST00000320356.2
ENST00000541220.1 ENST00000483967.1 ENST00000536783.1 |
EZH2
|
enhancer of zeste homolog 2 (Drosophila) |
chr1_+_231664390 | 0.55 |
ENST00000366639.4
ENST00000413309.2 |
TSNAX
|
translin-associated factor X |
chr12_-_104359475 | 0.55 |
ENST00000553183.1
|
C12orf73
|
chromosome 12 open reading frame 73 |
chr15_+_52043758 | 0.55 |
ENST00000249700.4
ENST00000539962.2 |
TMOD2
|
tropomodulin 2 (neuronal) |
chr14_+_54863739 | 0.55 |
ENST00000541304.1
|
CDKN3
|
cyclin-dependent kinase inhibitor 3 |
chr19_+_1248547 | 0.55 |
ENST00000586757.1
ENST00000300952.2 |
MIDN
|
midnolin |
chr14_+_54863682 | 0.55 |
ENST00000543789.2
ENST00000442975.2 ENST00000458126.2 ENST00000556102.2 |
CDKN3
|
cyclin-dependent kinase inhibitor 3 |
chr9_+_125703282 | 0.55 |
ENST00000373647.4
ENST00000402311.1 |
RABGAP1
|
RAB GTPase activating protein 1 |
chr1_+_155036204 | 0.54 |
ENST00000368409.3
ENST00000359751.4 ENST00000427683.2 ENST00000556931.1 ENST00000505139.1 |
EFNA4
EFNA3
EFNA3
|
ephrin-A4 ephrin-A3 Ephrin-A3; Uncharacterized protein; cDNA FLJ57652, highly similar to Ephrin-A3 |
chr4_+_78078304 | 0.54 |
ENST00000316355.5
ENST00000354403.5 ENST00000502280.1 |
CCNG2
|
cyclin G2 |
chr17_+_75447326 | 0.53 |
ENST00000591088.1
|
SEPT9
|
septin 9 |
chr14_+_54976603 | 0.53 |
ENST00000557317.1
|
CGRRF1
|
cell growth regulator with ring finger domain 1 |
chr5_-_137514333 | 0.53 |
ENST00000411594.2
ENST00000430331.1 |
BRD8
|
bromodomain containing 8 |
chr4_+_78079450 | 0.52 |
ENST00000395640.1
ENST00000512918.1 |
CCNG2
|
cyclin G2 |
chr14_+_54863667 | 0.52 |
ENST00000335183.6
|
CDKN3
|
cyclin-dependent kinase inhibitor 3 |
chr18_+_6729698 | 0.51 |
ENST00000383472.4
|
ARHGAP28
|
Rho GTPase activating protein 28 |
chr7_-_140178775 | 0.51 |
ENST00000474576.1
ENST00000473444.1 ENST00000471104.1 |
MKRN1
|
makorin ring finger protein 1 |
chr14_+_85996507 | 0.51 |
ENST00000554746.1
|
FLRT2
|
fibronectin leucine rich transmembrane protein 2 |
chr4_-_85887503 | 0.51 |
ENST00000509172.1
ENST00000322366.6 ENST00000295888.4 ENST00000502713.1 |
WDFY3
|
WD repeat and FYVE domain containing 3 |
chr1_+_196621002 | 0.51 |
ENST00000367429.4
ENST00000439155.2 |
CFH
|
complement factor H |
chr6_-_112575758 | 0.51 |
ENST00000431543.2
ENST00000453937.2 ENST00000368638.4 ENST00000389463.4 |
LAMA4
|
laminin, alpha 4 |
chr5_-_148930960 | 0.50 |
ENST00000261798.5
ENST00000377843.2 |
CSNK1A1
|
casein kinase 1, alpha 1 |
chr18_-_52989525 | 0.50 |
ENST00000457482.3
|
TCF4
|
transcription factor 4 |
chr7_-_148581251 | 0.50 |
ENST00000478654.1
ENST00000460911.1 ENST00000350995.2 |
EZH2
|
enhancer of zeste homolog 2 (Drosophila) |
chr5_+_138677515 | 0.50 |
ENST00000265192.4
ENST00000511706.1 |
PAIP2
|
poly(A) binding protein interacting protein 2 |
chr22_-_23484246 | 0.50 |
ENST00000216036.4
|
RTDR1
|
rhabdoid tumor deletion region gene 1 |
chr14_-_81425828 | 0.50 |
ENST00000555529.1
ENST00000556042.1 ENST00000556981.1 |
CEP128
|
centrosomal protein 128kDa |
chr11_-_124806297 | 0.50 |
ENST00000298251.4
|
HEPACAM
|
hepatic and glial cell adhesion molecule |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.5 | 20.4 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
1.2 | 4.9 | GO:0009956 | radial pattern formation(GO:0009956) |
0.9 | 3.8 | GO:0003138 | primary heart field specification(GO:0003138) sinoatrial valve development(GO:0003172) sinoatrial valve morphogenesis(GO:0003185) |
0.6 | 4.3 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.6 | 2.3 | GO:0035948 | N-terminal peptidyl-lysine acetylation(GO:0018076) positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.5 | 1.6 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.5 | 1.5 | GO:1904956 | regulation of endodermal cell fate specification(GO:0042663) regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
0.5 | 2.4 | GO:0060023 | soft palate development(GO:0060023) |
0.5 | 1.4 | GO:0021986 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
0.4 | 3.1 | GO:0097338 | response to clozapine(GO:0097338) |
0.4 | 1.3 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
0.4 | 1.3 | GO:0048203 | vesicle targeting, trans-Golgi to endosome(GO:0048203) |
0.4 | 1.2 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
0.4 | 1.1 | GO:0036333 | hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
0.3 | 10.7 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
0.3 | 1.0 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.3 | 1.6 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.3 | 2.4 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
0.3 | 0.9 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.3 | 2.5 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) |
0.3 | 1.9 | GO:2000332 | lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) blood microparticle formation(GO:0072564) regulation of blood microparticle formation(GO:2000332) positive regulation of blood microparticle formation(GO:2000334) |
0.3 | 0.8 | GO:0071790 | spindle pole body duplication(GO:0030474) spindle pole body organization(GO:0051300) spindle pole body localization(GO:0070631) establishment of spindle pole body localization(GO:0070632) spindle pole body localization to nuclear envelope(GO:0071789) establishment of spindle pole body localization to nuclear envelope(GO:0071790) |
0.2 | 8.4 | GO:0060065 | uterus development(GO:0060065) |
0.2 | 6.6 | GO:0072189 | ureter development(GO:0072189) |
0.2 | 1.5 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.2 | 0.4 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
0.2 | 1.5 | GO:0097501 | detoxification of inorganic compound(GO:0061687) stress response to metal ion(GO:0097501) |
0.2 | 0.6 | GO:1903028 | positive regulation of opsonization(GO:1903028) |
0.2 | 2.4 | GO:0014894 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.2 | 2.9 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.2 | 3.8 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.2 | 0.6 | GO:1990926 | short-term synaptic potentiation(GO:1990926) |
0.2 | 1.0 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.2 | 0.4 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
0.2 | 0.6 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.2 | 5.8 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.2 | 3.4 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.2 | 0.5 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
0.2 | 0.5 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.2 | 2.3 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.2 | 0.5 | GO:0005988 | lactose metabolic process(GO:0005988) lactose biosynthetic process(GO:0005989) |
0.2 | 0.2 | GO:0033092 | positive regulation of immature T cell proliferation in thymus(GO:0033092) |
0.2 | 0.5 | GO:0043396 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) |
0.2 | 0.6 | GO:0046351 | sucrose biosynthetic process(GO:0005986) disaccharide biosynthetic process(GO:0046351) |
0.2 | 0.2 | GO:1902499 | positive regulation of protein autoubiquitination(GO:1902499) |
0.2 | 0.8 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
0.1 | 0.4 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
0.1 | 0.6 | GO:2001012 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.1 | 0.6 | GO:0036269 | positive regulation of chronic inflammatory response(GO:0002678) swimming behavior(GO:0036269) |
0.1 | 1.9 | GO:0072307 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
0.1 | 0.4 | GO:0021938 | positive regulation of hh target transcription factor activity(GO:0007228) ventral midline development(GO:0007418) smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
0.1 | 0.8 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.1 | 2.4 | GO:0008595 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.1 | 0.4 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
0.1 | 0.3 | GO:0031133 | regulation of axon diameter(GO:0031133) |
0.1 | 0.6 | GO:0006696 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) |
0.1 | 0.6 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.1 | 0.6 | GO:2000620 | positive regulation of histone H4-K16 acetylation(GO:2000620) |
0.1 | 1.1 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
0.1 | 1.2 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 1.2 | GO:0042659 | regulation of cell fate specification(GO:0042659) |
0.1 | 1.4 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.1 | 0.7 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.1 | 0.2 | GO:1902811 | tongue muscle cell differentiation(GO:0035981) positive regulation of skeletal muscle fiber differentiation(GO:1902811) regulation of tongue muscle cell differentiation(GO:2001035) positive regulation of tongue muscle cell differentiation(GO:2001037) |
0.1 | 0.3 | GO:0052047 | interaction with other organism via secreted substance involved in symbiotic interaction(GO:0052047) |
0.1 | 4.3 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.1 | 0.2 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.1 | 0.4 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.1 | 0.5 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.1 | 0.3 | GO:0072560 | glandular epithelial cell maturation(GO:0002071) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) type B pancreatic cell maturation(GO:0072560) |
0.1 | 0.3 | GO:0018057 | peptidyl-lysine oxidation(GO:0018057) |
0.1 | 0.3 | GO:0034091 | regulation of maintenance of sister chromatid cohesion(GO:0034091) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) negative regulation of sister chromatid cohesion(GO:0045875) |
0.1 | 0.7 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.1 | 1.3 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 0.5 | GO:1905247 | regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902959) positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) regulation of aspartic-type peptidase activity(GO:1905245) positive regulation of aspartic-type peptidase activity(GO:1905247) |
0.1 | 0.6 | GO:0050893 | sensory processing(GO:0050893) |
0.1 | 2.1 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.1 | 1.1 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.1 | 1.8 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.1 | 0.4 | GO:0070980 | biphenyl catabolic process(GO:0070980) |
0.1 | 0.9 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.1 | 0.7 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.1 | 0.8 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.1 | 0.2 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.1 | 1.2 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.1 | 0.8 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.1 | 0.5 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.1 | 0.7 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.1 | 0.5 | GO:0051013 | microtubule severing(GO:0051013) |
0.1 | 0.8 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.1 | 0.5 | GO:0035973 | aggrephagy(GO:0035973) |
0.1 | 0.5 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.1 | 0.6 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.1 | 1.2 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.1 | 1.6 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.0 | 2.6 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.0 | 0.4 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.0 | 0.5 | GO:0031936 | DNA replication-dependent nucleosome assembly(GO:0006335) negative regulation of chromatin silencing(GO:0031936) DNA replication-dependent nucleosome organization(GO:0034723) |
0.0 | 0.2 | GO:0034473 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) |
0.0 | 0.1 | GO:1990637 | response to prolactin(GO:1990637) |
0.0 | 0.5 | GO:2000288 | positive regulation of myoblast proliferation(GO:2000288) |
0.0 | 1.3 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.0 | 0.1 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.0 | 0.2 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.0 | 0.5 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.0 | 0.6 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.0 | 0.2 | GO:1903786 | mycotoxin catabolic process(GO:0043387) aflatoxin catabolic process(GO:0046223) organic heteropentacyclic compound catabolic process(GO:1901377) regulation of glutathione biosynthetic process(GO:1903786) positive regulation of glutathione biosynthetic process(GO:1903788) |
0.0 | 1.2 | GO:0007625 | grooming behavior(GO:0007625) |
0.0 | 1.2 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.0 | 0.7 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
0.0 | 0.6 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.0 | 0.3 | GO:0007144 | female meiosis I(GO:0007144) |
0.0 | 0.4 | GO:0015889 | cobalamin transport(GO:0015889) |
0.0 | 2.5 | GO:0006301 | postreplication repair(GO:0006301) |
0.0 | 2.1 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.0 | 9.0 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.0 | 0.6 | GO:0097264 | self proteolysis(GO:0097264) |
0.0 | 0.2 | GO:1904550 | chemotaxis to arachidonic acid(GO:0034670) response to arachidonic acid(GO:1904550) |
0.0 | 1.5 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.0 | 0.2 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.0 | 0.7 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.0 | 0.3 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.0 | 1.3 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
0.0 | 0.8 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.0 | 0.4 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.0 | 0.2 | GO:1903232 | melanosome assembly(GO:1903232) |
0.0 | 0.2 | GO:2000741 | asymmetric neuroblast division(GO:0055059) positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.0 | 0.1 | GO:0002188 | translation reinitiation(GO:0002188) |
0.0 | 0.2 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.0 | 0.3 | GO:0060789 | hair follicle placode formation(GO:0060789) |
0.0 | 0.2 | GO:0070162 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) |
0.0 | 0.0 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.0 | 0.3 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) pyramidal neuron development(GO:0021860) |
0.0 | 0.4 | GO:0007567 | parturition(GO:0007567) |
0.0 | 0.1 | GO:0035617 | stress granule disassembly(GO:0035617) |
0.0 | 0.3 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.4 | GO:0030575 | nuclear body organization(GO:0030575) |
0.0 | 0.0 | GO:1901671 | regulation of superoxide dismutase activity(GO:1901668) positive regulation of superoxide dismutase activity(GO:1901671) positive regulation of removal of superoxide radicals(GO:1904833) |
0.0 | 0.2 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.0 | 0.2 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.0 | 0.2 | GO:0098700 | neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.0 | 0.3 | GO:0006069 | ethanol oxidation(GO:0006069) |
0.0 | 0.2 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.0 | 0.6 | GO:0015695 | organic cation transport(GO:0015695) |
0.0 | 0.1 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.0 | 0.1 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.0 | 0.4 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.0 | 2.9 | GO:0002576 | platelet degranulation(GO:0002576) |
0.0 | 0.1 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
0.0 | 0.5 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.0 | 4.3 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.0 | 0.1 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.0 | 0.4 | GO:0034389 | lipid particle organization(GO:0034389) |
0.0 | 0.5 | GO:0051923 | sulfation(GO:0051923) |
0.0 | 0.1 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.0 | 0.2 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.0 | 0.2 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.0 | 0.4 | GO:0035329 | hippo signaling(GO:0035329) |
0.0 | 0.2 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
0.0 | 1.4 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
0.0 | 0.0 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
0.0 | 0.2 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.0 | 1.1 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.0 | 0.9 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.0 | 0.2 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.0 | 0.3 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.0 | 0.7 | GO:0008542 | visual learning(GO:0008542) |
0.0 | 0.1 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.0 | 0.2 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.0 | 0.0 | GO:0036371 | protein localization to T-tubule(GO:0036371) |
0.0 | 0.1 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 0.8 | GO:0070762 | nuclear pore transmembrane ring(GO:0070762) |
0.3 | 1.3 | GO:0060200 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
0.2 | 2.1 | GO:0000125 | PCAF complex(GO:0000125) |
0.2 | 0.7 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.1 | 1.2 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.1 | 3.1 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 4.8 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 0.3 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.1 | 0.6 | GO:0070554 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) synaptobrevin 2-SNAP-25-syntaxin-3-complexin complex(GO:0070554) |
0.1 | 1.1 | GO:0016013 | syntrophin complex(GO:0016013) |
0.1 | 0.6 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.1 | 1.4 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.1 | 0.5 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
0.1 | 0.6 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.1 | 0.5 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.1 | 0.5 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.1 | 42.8 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 1.1 | GO:0045120 | pronucleus(GO:0045120) |
0.1 | 0.8 | GO:0035102 | PRC1 complex(GO:0035102) |
0.1 | 3.7 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.1 | 1.3 | GO:0000812 | Swr1 complex(GO:0000812) |
0.1 | 0.6 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.1 | 13.7 | GO:0030018 | Z disc(GO:0030018) |
0.1 | 0.8 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 0.8 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.1 | 2.3 | GO:0005605 | basal lamina(GO:0005605) |
0.1 | 2.5 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 0.4 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.1 | 0.2 | GO:0044753 | amphisome(GO:0044753) |
0.0 | 0.7 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.0 | 1.2 | GO:0031105 | septin complex(GO:0031105) |
0.0 | 0.4 | GO:0005638 | lamin filament(GO:0005638) |
0.0 | 0.2 | GO:0031905 | early endosome lumen(GO:0031905) |
0.0 | 0.7 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.0 | 1.5 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 7.1 | GO:0043197 | dendritic spine(GO:0043197) |
0.0 | 0.6 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 0.5 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.0 | 5.6 | GO:0000922 | spindle pole(GO:0000922) |
0.0 | 2.3 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 3.7 | GO:0016363 | nuclear matrix(GO:0016363) |
0.0 | 0.4 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.0 | 0.1 | GO:0031417 | NatC complex(GO:0031417) |
0.0 | 0.5 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.0 | 2.4 | GO:0005884 | actin filament(GO:0005884) |
0.0 | 0.1 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.0 | 0.2 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.0 | 0.6 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.0 | 0.1 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.0 | 1.1 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.4 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.0 | 1.8 | GO:0042641 | actomyosin(GO:0042641) |
0.0 | 0.4 | GO:0031528 | microvillus membrane(GO:0031528) |
0.0 | 0.2 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 0.9 | GO:0097542 | ciliary tip(GO:0097542) |
0.0 | 1.0 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.0 | 0.4 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.8 | GO:0044291 | cell-cell contact zone(GO:0044291) |
0.0 | 2.8 | GO:0031901 | early endosome membrane(GO:0031901) |
0.0 | 0.3 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.0 | 0.4 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.2 | GO:0051233 | spindle midzone(GO:0051233) |
0.0 | 1.6 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.0 | 0.9 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.0 | 0.7 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 0.1 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.0 | 0.2 | GO:0030478 | actin cap(GO:0030478) |
0.0 | 0.2 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.0 | 0.3 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.0 | 0.8 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.0 | 0.9 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 20.2 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
1.0 | 10.7 | GO:0030274 | LIM domain binding(GO:0030274) |
0.5 | 3.8 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.4 | 1.5 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.4 | 1.5 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.3 | 1.9 | GO:0070892 | lipoteichoic acid receptor activity(GO:0070892) |
0.3 | 2.3 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.3 | 3.6 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.2 | 1.3 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.2 | 3.8 | GO:0003680 | AT DNA binding(GO:0003680) |
0.2 | 5.8 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.2 | 0.6 | GO:0033754 | indoleamine 2,3-dioxygenase activity(GO:0033754) |
0.2 | 0.7 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.2 | 3.1 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.2 | 0.5 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.2 | 0.8 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.2 | 0.6 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
0.2 | 2.5 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.2 | 0.6 | GO:0004310 | farnesyl-diphosphate farnesyltransferase activity(GO:0004310) squalene synthase activity(GO:0051996) |
0.1 | 0.8 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
0.1 | 0.9 | GO:0004522 | ribonuclease A activity(GO:0004522) |
0.1 | 5.4 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 0.5 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.1 | 1.1 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.1 | 0.8 | GO:1904315 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
0.1 | 0.9 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.1 | 0.4 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.1 | 1.3 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.1 | 1.1 | GO:0039706 | co-receptor binding(GO:0039706) |
0.1 | 0.3 | GO:0015616 | DNA translocase activity(GO:0015616) |
0.1 | 3.8 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.1 | 1.8 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.1 | 0.1 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.1 | 0.5 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.5 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.1 | 1.3 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.1 | 1.4 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.1 | 1.7 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 1.0 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 0.2 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.1 | 0.3 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 1.4 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.0 | 1.3 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.0 | 0.5 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.0 | 0.1 | GO:0035500 | MH2 domain binding(GO:0035500) |
0.0 | 0.4 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.6 | GO:0005113 | patched binding(GO:0005113) |
0.0 | 0.4 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 0.2 | GO:0005499 | vitamin D binding(GO:0005499) |
0.0 | 0.7 | GO:0043295 | glutathione binding(GO:0043295) |
0.0 | 0.9 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.0 | 14.8 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.0 | 0.1 | GO:0099609 | microtubule lateral binding(GO:0099609) |
0.0 | 2.3 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 1.1 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 0.1 | GO:0010465 | nerve growth factor receptor activity(GO:0010465) |
0.0 | 1.3 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 0.8 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.8 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.3 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.0 | 0.3 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.0 | 0.2 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.0 | 4.8 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.0 | 1.5 | GO:0035064 | methylated histone binding(GO:0035064) |
0.0 | 0.7 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.0 | 0.5 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.0 | 1.1 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.0 | 0.4 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.0 | 0.2 | GO:0016273 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.0 | 0.9 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.0 | 0.2 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.0 | 0.6 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.4 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.0 | 0.7 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 0.6 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.0 | 0.1 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.0 | 0.2 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.0 | 0.2 | GO:0055104 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
0.0 | 0.2 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.0 | 0.3 | GO:0070513 | death domain binding(GO:0070513) |
0.0 | 0.2 | GO:0045159 | myosin II binding(GO:0045159) |
0.0 | 0.6 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.0 | 0.7 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.0 | 0.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.0 | 0.4 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.0 | 1.6 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.0 | 4.0 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.0 | 0.0 | GO:0016211 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
0.0 | 2.8 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.0 | 0.0 | GO:0004796 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
0.0 | 0.6 | GO:0043531 | ADP binding(GO:0043531) |
0.0 | 0.0 | GO:0005497 | androgen binding(GO:0005497) |
0.0 | 0.4 | GO:0030371 | translation repressor activity(GO:0030371) |
0.0 | 0.1 | GO:0070905 | serine binding(GO:0070905) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 7.5 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 12.4 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 4.4 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 3.4 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 1.4 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 2.6 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 4.7 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.9 | PID FOXO PATHWAY | FoxO family signaling |
0.0 | 0.3 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 3.8 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 0.3 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 1.5 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.6 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.3 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 1.0 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 1.1 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.6 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.0 | 0.9 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 0.9 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 0.3 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 0.5 | PID EPHA FWDPATHWAY | EPHA forward signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 2.3 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 7.9 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 7.1 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.1 | 1.9 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.1 | 2.3 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 6.1 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 1.4 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 0.7 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 1.3 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 3.1 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.0 | 1.9 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.0 | 0.6 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.0 | 0.6 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 1.1 | REACTOME KINESINS | Genes involved in Kinesins |
0.0 | 0.8 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 0.5 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.0 | 0.4 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.0 | 0.9 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.0 | 0.3 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 0.3 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 1.2 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 2.0 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 0.6 | REACTOME SIGNALING BY FGFR1 MUTANTS | Genes involved in Signaling by FGFR1 mutants |
0.0 | 0.3 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.6 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 1.3 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.4 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.4 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.6 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 0.2 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.0 | 0.3 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |